Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2014-09-29FDA Approved: ACYCLOVIR — Supplemental Application (ACTAVIS PHARMA, INC.)
FDA approved a supplemental application for Acyclovir (Actavis Pharma) to update the labeling.
-
FDA approval · 2014-09-10FDA Approved: FAMCICLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of famciclovir under an original ANDA from Camber Pharmaceuticals, Inc.
-
FDA approval · 2014-08-19FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original (ANDA) application for a generic acyclovir product from Zydus Pharmaceuticals (USA) Inc., enabling a generic versi…
-
FDA approval · 2014-06-18FDA Approved: ACYCLOVIR — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for a generic acyclovir product.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster [Phase 4]
Phase 4 clinical trial comparing Vacyless to Valtrex in patients with herpes zoster, with the study status reported as completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-01FDA Approved: ACYCLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for acyclovir from Teva Pharmaceuticals USA, Inc., updating the drug’s approval details. The supplem…
-
FDA approval · 2014-03-06FDA Approved: ACYCLOVIR — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original ANDA for acyclovir from Nivagen Pharmaceuticals, authorizing a generic version of the antiviral for several herpes…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: VZV PCR Sampling Validation Study
A completed clinical trial evaluating Varicella Zoster Virus PCR sampling validation for herpes zoster.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025) [Phase 3]
A Phase 3 clinical trial evaluating safety, tolerability, and immunogenicity of Zoster Vaccine Live (ZOSTAVAX) in healthy adults in India ha…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster [Phase 2]
Phase 2b trial of EPB-348 for herpes zoster has completed; the update does not provide efficacy results in the excerpt.
-
FDA approval · 2013-11-15FDA Approved: ACYCLOVIR — Original Application (Modavar Pharmaceuticals LLC)
FDA approved Modavar Pharmaceuticals LLC's original ANDA for acyclovir, enabling a generic version of the antiviral for common herpes simple…
-
FDA approval · 2013-10-11FDA Approved: ACYCLOVIR SODIUM — Original Application (Eugia US LLC)
FDA approved the original application for acyclovir sodium by Eugia US LLC, a generic version of acyclovir.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) [Phase 4]
Phase 4 study evaluating safety and immunogenicity of ZOSTAVAX in Korean adults completed. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital [NA]
This clinical trial update notes increased use of the herpes zoster vaccine at NYU Langone Health and Bellevue Hospital; the study has compl…
-
FDA approval · 2013-07-23FDA Approved: FAMCICLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic famciclovir from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Shingles Prevention Study [Phase 3]
Phase 3 results from the Shingles Prevention Study have completed, evaluating a shingles vaccine for prevention of herpes zoster and posther…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1) [Phase 3]
Phase 3 trial update evaluating the safety and immunogenicity of Merck's ZOSTAVAX vaccine produced with an Alternative Manufacturing Process…
-
FDA approval · 2013-05-30FDA Approved: FAMCICLOVIR — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for famciclovir from Macleods Pharmaceuticals Limited, authorizing an update to the approved AND…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029) [Phase 3]
This Phase 3 clinical trial update reports safety, tolerability, and immunogenicity data for a booster dose of the live varicella-zoster vac…
-
FDA approval · 2013-05-14FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for VALACYCLOVIR from Sun Pharmaceutical Industries, Inc., under an approved ANDA.
-
FDA approval · 2013-03-20FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (TIME CAP LABORATORIES, INC.)
FDA approved a supplemental application for valacyclovir hydrochloride from Time Cap Laboratories, Inc. The action finalizes the regulatory …
-
FDA approval · 2013-03-15FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited. This action supports the continued…
-
CLINICAL_TRIALS withdrawal · 2013-03-01Clinical Trial Update: Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a Varicella Zoster Virus vaccine to prevent reactivation in HIV-positive individuals has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2) [Phase 1]
This update reports the completion and results posting of a Phase 1 study evaluating intradermal administration of ZOSTAVAX for herpes zoste…
-
CLINICAL_TRIALS research · 2013-01-24Clinical Trial Update: Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block [NA]
This clinical trial update reports anatomical measurements of the distances from the cricoid cartilage to targets used in stellate ganglion …